Correlation analyses of clinical data and mutational status for AML patients with IDH1 mutations indicated that the presence of IDH1 mutations, in cases with normal cytogenetics and with wild-type nucleophosmin-1 ( NPM1 ), a commonly mutated gene in AML that has been known for some time, predicted a worse prognosis, although we did not reach statistical significance with our cohort.
1
—
—